Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 319.00
Ask: 322.00
Change: 1.00 (0.31%)
Spread: 3.00 (0.94%)
Open: 322.00
High: 322.00
Low: 322.00
Prev. Close: 321.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Project Helix

19 Mar 2019 15:16

RNS Number : 3441T
Bank of Cyprus Holdings PLC
19 March 2019
 

Announcement

 

Update on Project Helix - Agreement for the sale of a portfolio of non-performing loans

 

 

Nicosia, 19 March 2019

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

 

Further to the announcement of 28 August 20181 in relation to the agreement for the sale of a portfolio of non-performing loans, known as "Project Helix", or the "Transaction", Bank of Cyprus Holdings Public Limited Company ("BOCH" and, together with its subsidiaries, the "Group") announces that it has received approval from the ECB for the Significant Risk Transfer ("SRT") benefit from the Transaction.

This is an important step towards completion of the Transaction, which remains subject to various outstanding conditions precedent1. Completion is currently expected to occur in early 2Q2019.

As previously reported, the Transaction reduces the Group's non-performing exposures (NPEs) by €2.7 bn and improves the NPE ratio from 47% to 36%3. The NPE provisioning coverage ratio pro forma for the Transaction stands at 47%3.

On completion, the derecognition of the Helix portfolio is expected to have a positive impact on the capital ratios of 160 basis points2, resulting from the release of risk weighted assets.

As at 31 December 2018, as previously reported, the Group's phased-in CET1 ratio and Total capital ratio, pro forma for both DTC2 and Helix, stood at 15.4% and 18.3% respectively.

For further information, please contact Investor Relations at investors@bankofcyprus.com.

[1] Further to the announcement of 28 August 2018 and updates provided with the publication of the Group financial results for the nine months ended 30 September 2018 and the preliminary Group financial results for the year ended 31 December 2018

2 Refer to slide 36 of the presentation for the preliminary Group financial results for the year ended 31 December 2018 published on 4 March 2019

3 Based on the preliminary Group financial results for the year ended 31 December 2018

4 DTC refers to the amendments in the legislation adopted by the Cyprus Parliament on 1 March 2019 and was published on the Official Gazette of the Republic on 15 March 2019

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 112 branches in Cyprus. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,146 staff worldwide. At 31 December 2018, the Group's Total Assets amounted to €22.1 bn and Total Equity was €2.4 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURLLFLEVVIALIA
Date   Source Headline
4th Jul 20198:39 amRNSPDMR Notification of Transaction - Arapoglou
3rd Jul 20193:55 pmRNSTR-1 Notification of Major Holding- Caius Capital
3rd Jul 20199:42 amRNSDirector/PDMR Shareholding-Arapoglou
2nd Jul 20191:31 pmRNSDirector/PDMR Shareholding-Arapoglou
28th Jun 20192:13 pmRNSFurther re (Completion of Project Helix)
13th Jun 201911:01 amRNSStandard Form TR-1 Caius Capital
13th Jun 20199:20 amRNSElection of Chairman
4th Jun 20197:30 amRNSAgreement for the sale of investment in CNP Cyprus
14th May 20193:06 pmRNSDirectorate Change
14th May 20192:56 pmRNSResult of AGM 2019
13th May 20194:42 pmRNSAppointment of Group Chief Executive Officer
13th May 20194:10 pmRNSDoc re. (1Q2019 FR Investor Presentation)
13th May 20193:52 pmRNS1st Quarter Results 2019
3rd May 20198:31 amRNSNotice of Results 1Q2019
10th Apr 20199:31 amRNSNotice of AGM
3rd Apr 201910:32 amRNSPillar 3 Disclosures for the year 2018
28th Mar 20192:43 pmRNSBOC Annual Financial Report 2018
28th Mar 20192:42 pmRNSBOCH Annual Financial Report 2018
28th Mar 20191:48 pmRNSGroup Financial Results FY2018
28th Mar 20191:43 pmRNSDoc re. (Investor Presentation FY2018)
27th Mar 20192:17 pmRNSDirector/PDMR Shareholding- Josef Ackermann
19th Mar 20193:16 pmRNSUpdate on Project Helix
15th Mar 201912:55 pmRNSNotice of Results - Audited FY2018 FS
4th Mar 20198:17 amRNSInvestor Presentation Announcement Prel FY2018 FR
4th Mar 20197:13 amRNSNotice of Resignation of Group CEO
4th Mar 20197:00 amRNSPreliminary FY2018 Group Financial Results
26th Feb 201912:14 pmRNSChanges in the Board Composition
19th Feb 20196:17 pmRNSAnnouncement
14th Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:03 amRNSResignation of Board Member
27th Dec 20189:52 amRNSIssuance of Additional Tier 1 Capital Securities
21st Dec 20184:35 pmRNSPrice Monitoring Extension
19th Dec 20182:48 pmRNSIssuance of Additional Tier 1 Capital Securities
18th Dec 20184:40 pmRNSSecond Price Monitoring Extn
18th Dec 20184:35 pmRNSPrice Monitoring Extension
14th Dec 20185:32 pmRNSEU-wide Transparency Exercise 2018
14th Dec 20187:00 amRNSAdditional Tier 1 Capital Securities
29th Nov 201810:39 amRNSPDMR Shareholding
26th Nov 20186:27 pmRNSDoc re. (Investor Presentation 9M2018 FR)
26th Nov 20185:33 pmRNS3rd Quarter Results
26th Nov 20185:28 pmRNSDoc re. (Investor Presentation 9M2018 FR)
23rd Nov 20183:40 pmRNSCompletion of the sale of Bank of Cyprus UK Ltd
23rd Nov 20183:28 pmRNSDisposal
15th Nov 20188:47 amRNSNotice of Results - 3rd Quarter 2018
29th Oct 201812:25 pmRNSDate of Annual General Meeting
28th Aug 20181:25 pmRNSResolutions of AGM 2018
28th Aug 201810:37 amRNSBank of Cyprus priced EUR 220m of AT1 Capital Sec
28th Aug 201810:17 amRNSHalf-year Report
28th Aug 20187:05 amRNSDoc re. 1H2018 FR Investor Presentation
28th Aug 20187:05 amRNSChairman's intention to step down&CEO Ext. of App.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.